Delivery Order SPE2DB24D2205-SPE2DB25FEFPL
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for the supply of Concerta ER 36 mg tablets (100 count units) with a ceiling value of $4,310.92. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 5, 2025. The award fulfills the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Concerta ER 18 mg tablets (100 count) valued at $18,688.60 under a firm fixed price contract. This delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a child...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $19,082.45. This firm fixed-price delivery order, which is expected to be completed by August 22, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,289.80 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Concerta ER 18 mg tablets (100 count) with a contract value of $3,513.92. This is a firm fixed-price delivery order with an ultimate completion date of June 4, 2025. The award was made through open competition with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order for Concerta 54mg tablets (100-count units) valued at $7,020.98 under a firm fixed-price contract with the Defense Logistics Agency Medical Supply Chain. The award, made on July 30, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of July 31, 2025. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,675.27 to AmerisourceBergen Drug Corp for the supply of Concerta HCL 18mg tablets (100 count) on July 31, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- AmerisourceBergen Drug Corp was awarded a delivery order for Concerta ER 27 mg tablets (100-count units) valued at $3,162.83 under a firm fixed price contract with the Defense Logistics Agency (DLA). The award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a competitive award with no set-aside designation. Performance will be executed from the contractor's Corporate Office location in Conshohocken, PA. This delivery order is a child contract under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 36mg Concerta ER tablets valued at $14,709.30 under a firm fixed price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFPLDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen supplies a broad range of medications and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Concerta ER supply supports military personnel medication needs within the DLA's extensive pharmaceutical distribution network. This delivery order exemplifies the company's role as a primary vendor for controlled and specialty medications distributed through federal medical supply chains to military installations and veteran healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 7/30/25 |